‘We’re duplicating everything’: CEO questions outpatient boom 

Advertisement

Main Line Health President and CEO Ed Jimenez has spent years building ambulatory networks. He also said the industry is telling an incomplete story about where care is going.

“Everything’s going ambulatory. Everything’s going outpatient,” Mr. Jimenez said of the narrative during a Nov. 3 conversation with Becker’s. “And it’s such an incomplete sentence because the reality is we’re duplicating everything.”

His argument: When a procedure moves to an ASC or other outpatient site, the hospital capacity that used to handle it does not close.

“If you think about what’s moved ambulatory, we haven’t turned around and closed it inside of a hospital,” he said. “It still exists. We have duplicated it.”

Mr. Jimenez took the helm of the Radnor, Pa.-based system, which includes four acute care hospitals and a rehabilitation hospital, in June 2025. He previously served as CEO of Newark, N.J.-based University Hospital and, for nearly a decade, CEO of Gainesville, Fla.-based UF Health. Main Line Health said at his appointment that he developed an ambulatory strategy at UF Health centered on freestanding emergency departments and imaging, therapy, surgery and urgent care centers.

Mr. Jimenez did not dispute that ambulatory sites are cheaper to run. His concern is what stays behind.

“This notion, especially with insurers, that it’s a lower cost environment, sure, it’s less expensive to build. We can likely staff it differently, operate it in a more efficient way to lower its cost,” he said. “But I don’t get the refund on the operating rooms that remain back in the hospital. They were built, they’re in our depreciation. Those expenditures are living in our ecosphere.”

He said there are good reasons for the duplication, including convenience, efficiency and speed. He acknowledged the view may be an unpopular one in an industry focused on cutting waste.

“We are in an industry that prides itself on trying to figure out how to eliminate waste,” he said. “There’s a lot of us across the country that are going to prove to you and others we’re duplicating things.”

His comments come as payers and policymakers continue shifting procedures toward lower-cost outpatient settings, including in Main Line Health’s market.

Independence Blue Cross launched a site-of-care review June 1 for select elective procedures requested in hospital outpatient departments, covering commercial and Medicare Advantage members. At the time, Main Line Health said the policy could complicate care coordination when physicians lack privileges at available surgery centers. In September, IBX partnered with Penn Medicine and Regent Surgical to develop at least 18 ASCs across Pennsylvania, New Jersey and Delaware.

At the federal level, CMS began a three-year phaseout of the inpatient-only list in 2026, removing 285 mostly musculoskeletal procedures in the first year, and added 560 codes to the ASC covered procedures list.

Advertisement

Next Up in Leadership

Advertisement